The Canadian Securities Exchange (CSE) is becoming increasingly popular with companies that are operating in Israel’s emerging cannabis sector.
In a statement, the CSE revealed Tuesday that three Israel-based cannabis companies including InnoCan Pharma Corp (CSE:INNO), Isracann Biosciences Inc (CSE:IPOT), and IM Cannabis Corp (CSE:IMCC) listed on the CSE over the past six weeks.
This represents the CSE's first listings from companies in Israel and is a result of a concerted push over the past two years to woo Israeli entrepreneurs eyeing a Canadian listing.
"We are delighted to welcome these three companies," said Canadian Securities Exchange CEO Richard Carleton in a statement.
"Israeli cannabis firms typically have a deep portfolio of intellectual property and are building access to the emerging European cannabis market. Many of these companies have a strong need to access the public capital markets for growth funding. The CSE can play a key role in helping them achieve their objectives," he added.
The CSE’s rapidly growing stock exchange is focused on working with entrepreneurs to access the capital markets in Canada and internationally. It’s efficient operating model and low fee structure help companies minimize their costs and maximize access to liquidity.
"We have established the CSE as the 'go-to' exchange for companies in the Israeli cannabis industry," said Carleton.
"Our international outreach efforts are continuing, not just in Israel but also across Europe, Asia, South America and the Caribbean,” he added.
The CSE has seen a rapid increase in issuers, hitting 500 in the first quarter of 2019, a jump of 47.5% compared to the first quarter of 2018. Its issuers, which are active in diverse industries such as cannabis, technology and mining, have raised more than C$4.2 billion in the last 12 months
The exchange was founded in 2004 and has corporate offices in Toronto, Ontario and Vancouver, British Columbia.
Contact Uttara Choudhury at email@example.com
Follow her on Twitter: @UttaraProactive